Notice of Interim Results

RNS Number : 5047V
Glenveagh Properties PLC
24 July 2018
 

 

 

 

 

24 July 2018

 

Glenveagh Properties PLC

Notice of Interim Results

Glenveagh Properties PLC ("Glenveagh" or the "Group") a leading Irish homebuilder listed on Euronext Dublin and the London Stock Exchange will issue its interim results for the period ended 30 June 2018 on Monday, 3 September 2018 at 7.00am (GMT).

A conference call for analysts and investors will take place at 8.30am (GMT) on the same morning to present the financial and operational results followed by a Q&A session. Dial in details as follows:

Ireland +353 (0) 1 2460271 / UK +44 (0) 20 3059 2697 / USA +1 347 532 1806;

Conference PIN 9730744.

 

For further information please contact:

Investors:

Media:

Glenveagh Properties PLC

 

Justin Bickle (CEO)

 

Michael Rice (CFO)

 

Conor Murtagh (Director, Strategy & IR)

 

investors@glenveagh.ie

Gordon MRM

 

Ray Gordon 087 241 7373

 

David Clerkin 087 830 1779

 

glenveagh@gordonmrm.ie

 

Note to Editors

Glenveagh Properties PLC (the "Group") is a leading Irish homebuilder listed on Euronext Dublin and the London Stock Exchange. With a focus on strategically located developments in the Greater Dublin Area, Cork, Limerick and Galway, the Group comprises two complementary divisions, Glenveagh Homes and Glenveagh Living.

Glenveagh Homes' delivers high quality starter homes to its private customers with selective developments of mid-size and executive houses and apartments in areas of high demand.

Glenveagh Living delivers houses and apartments for the public sector and institutional investors. Its Partnerships business focusses on mixed-tenure and joint venture opportunities with the public sector in Ireland, while its PRS business delivers large-scale private rental product for institutional investors.

www.glenveagh.ie


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORQXLFLVDFEBBX
UK 100

Latest directors dealings